VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 206 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $842,129 | -88.2% | 89,875 | -69.0% | 0.00% | -86.7% |
| Q2 2023 | $7,122,433 | -9.4% | 290,356 | -14.0% | 0.02% | -11.8% |
| Q1 2023 | $7,857,627 | +0.6% | 337,672 | +9.4% | 0.02% | -5.6% |
| Q4 2022 | $7,812,514 | +14.9% | 308,673 | -12.5% | 0.02% | +5.9% |
| Q3 2022 | $6,801,000 | +27.3% | 352,733 | +68.2% | 0.02% | +41.7% |
| Q2 2022 | $5,341,000 | +89.5% | 209,709 | +91.4% | 0.01% | +140.0% |
| Q1 2022 | $2,818,000 | +582.3% | 109,570 | +1053.6% | 0.01% | +400.0% |
| Q3 2021 | $413,000 | -33.5% | 9,498 | -21.6% | 0.00% | 0.0% |
| Q1 2021 | $621,000 | -16.1% | 12,111 | -43.8% | 0.00% | 0.0% |
| Q3 2020 | $740,000 | – | 21,543 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | 22,616,666 | $284,405,000 | 3.12% |
| INDUS CAPITAL PARTNERS, LLC | 681,936 | $8,575,000 | 1.68% |
| Alphabet Inc. | 1,666,666 | $20,958,000 | 1.27% |
| Temasek Holdings (Private) Ltd | 5,499,999 | $69,162,000 | 0.45% |
| Board of Trustees of The Leland Stanford Junior University | 38,905 | $490,000 | 0.06% |
| Baillie Gifford | 500,000 | $6,287,000 | 0.01% |
| Marshall Wace North America L.P. | 74,898 | $941,000 | 0.01% |
| Capital International Investors | 983,300 | $12,365,000 | 0.00% |
| Blackstone Inc. | 35,000 | $440,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,908 | $24,000 | 0.00% |